Richard A. Larson to Longitudinal Studies
This is a "connection" page, showing publications Richard A. Larson has written about Longitudinal Studies.
Connection Strength
0.030
-
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia. BMC Cancer. 2018 04 02; 18(1):359.
Score: 0.030